EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

The P2X7 Receptor as a Mechanistic Biomarker for Epilepsy

Tobias Engel iD

International Journal of Molecular Sciences · 2023

DOI: 10.3390/ijms24065410 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift International Journal of Molecular Sciences, 2023. Verfasst von Tobias Engel. Beteiligte Einrichtung: Department of Physiology and Medical Physics, RCSI, University of Medicine and Health Sciences, D02 YN77 Dublin, Ireland. Hauptthemen laut MEDLINE: Epilepsy, Epileptic Syndromes, Epilepsy, Generalized. Die Arbeit wurde bisher 24-mal zitiert (Crossref) und nennt 152 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Science Foundation Ireland, European Regional Development Fund.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Epilepsy, characterized by recurrent spontaneous seizures, is a heterogeneous group of brain diseases affecting over 70 million people worldwide. Major challenges in the management of epilepsy include its diagnosis and treatment. To date, video electroencephalogram (EEG) monitoring is the gold-standard diagnostic method, with no molecular biomarker in routine clinical use. Moreover, treatment based on anti-seizure medications (ASMs) remains ineffective in 30% of patients, and, even if seizure-suppressive, lacks disease-modifying potential. Current epilepsy research is, therefore, mainly focussed on the identification of new drugs with a different mechanism of action effective in patients not responding to current ASMs. The vast heterogeneity of epilepsy syndromes, including differences in underlying pathology, comorbidities and disease progression, represents, however, a particular challenge in drug discovery. Optimal treatment most likely requires the identification of new drug targets combined with diagnostic methods to identify patients in need of a specific treatment. Purinergic signalling via extracellularly released ATP is increasingly recognized to contribute to brain hyperexcitability and, consequently, drugs targeting this signalling system have been proposed as a new therapeutic strategy for epilepsy. Among the purinergic ATP receptors, the P2X7 receptor (P2X7R) has attracted particular attention as a novel target for epilepsy treatment, with P2X7Rs contributing to unresponsiveness to ASMs and drugs targeting the P2X7R modulating acute seizure severity and suppressing seizures during epilepsy. In addition, P2X7R expression has been reported to be altered in the brain and circulation in experimental models of epilepsy and patients, making it both a potential therapeutic and diagnostic target. The present review provides an update on the newest findings regarding P2X7R-based treatments for epilepsy and discusses the potential of P2X7R as a mechanistic biomarker.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

EpilepsyEpileptic SyndromesEpilepsy, GeneralizedHumansReceptors, Purinergic P2X7BrainBrain Damage, ChronicAdenosine Triphosphate

Stichwörter der Autor:innen

P2X7 receptordiagnosisepilepsypurinergic signallingseizurestreatment

Substanzen

Receptors, Purinergic P2X7Adenosine Triphosphate

Autor:innen und Institutionen

  • Department of Physiology and Medical Physics, RCSI, University of Medicine and Health Sciences, D02 YN77 Dublin, Ireland.
  • FutureNeuro, Science Foundation Ireland Research Centre for Chronic and Rare Neurological Diseases, RCSI, University of Medicine and Health Sciences, D02 YN77 Dublin, Ireland.

ORCID-Profile: Tobias Engel

Förderung

  • Science Foundation Ireland
  • European Regional Development Fund

Zitieren

APA

Engel, T. (2023). The P2X7 Receptor as a Mechanistic Biomarker for Epilepsy. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms24065410

Vancouver

Engel T. The P2X7 Receptor as a Mechanistic Biomarker for Epilepsy. International Journal of Molecular Sciences. 2023. doi:10.3390/ijms24065410

BibTeX
@article{Engel2023,
  author = {Engel, Tobias},
  title = {The P2X7 Receptor as a Mechanistic Biomarker for Epilepsy},
  journal = {International Journal of Molecular Sciences},
  year = {2023},
  doi = {10.3390/ijms24065410}
}
Kostenlos starten →